• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Sci Rep . Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiot

tetano

Editor, Senior Moderator
Sci Rep


. 2020 Nov 5;10(1):19116.
doi: 10.1038/s41598-020-75840-w.
Influenza virus infection augments susceptibility to respiratory Yersinia pestis exposure and impacts the efficacy of antiplague antibiotic treatments


Yaron Vagima[SUP] 1 [/SUP], David Gur[SUP] 2 [/SUP], Noam Erez[SUP] 3 [/SUP], Hagit Achdout[SUP] 3 [/SUP], Moshe Aftalion[SUP] 2 [/SUP], Yinon Levy[SUP] 2 [/SUP], Ayelet Zauberman[SUP] 2 [/SUP], Avital Tidhar[SUP] 2 [/SUP], Hila Gutman[SUP] 4 [/SUP], Shlomi Lazar[SUP] 4 [/SUP], Tomer Israely[SUP] 3 [/SUP], Nir Paran[SUP] 3 [/SUP], Sharon Melamed[SUP] 3 [/SUP], Tal Brosh-Nissimov[SUP] 5 [/SUP], Theodor Chitlaru[SUP] 2 [/SUP], Irit Sagi[SUP] 6 [/SUP], Emanuelle Mamroud[SUP] 7 [/SUP]



Affiliations

Abstract

Various respiratory viral infections in general and seasonal influenza in particular may increase the susceptibility to bacterial infections. Plague caused by Yersinia pestis endangers large populations during outbreaks or bioterrorism attacks. Recommended antibiotic countermeasures include well-established protocols based on animal studies and corroborated by effective treatment of human cases. Until now, prior exposure to viral respiratory infections was not taken into consideration when selecting the appropriate treatment for plague. Here, we show that as late as 25 days after exposure to influenza virus, convalescent mice still exhibited an increased susceptibility to sublethal doses of Y. pestis, presented with aberrant cytokine expression, and impaired neutrophil infiltration in the lungs. Increased levels of M2 alveolar macrophages and type II epithelial cells, as well as induction in metalloproteases expression and collagen and laminin degradation, suggested that the previous viral infection was under resolution, correlating with enhanced susceptibility to plague. Surprisingly, postexposure prophylaxis treatment with the recommended drugs revealed that ciprofloxacin was superior to doxycycline in mice recovering from influenza infection. These results suggest that after an influenza infection, the consequences, such as impaired immunity and lung tissue remodeling and damage, should be considered when treating subsequent Y. pestis exposure.
 
Back
Top Bottom